30 /100
MEDIUM RISK
Score updated May 30, 2026

GDTC — CytoMed Therapeutics Limited Dilution Risk Tracker

Track GDTC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GDTC — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
80
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

⛅
Watch
Minor dilution signals detected
15%
🔄 Reverse Split 30%
• 50-day avg $1.02 approaching $1 threshold
🔔 Track GDTC — Get forecast alerts →

💹 Market Data

Market Cap$13.84M
Shares Outstanding11.83M
Float1.84M
Cash$1.64M
Debt$378.1K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 67.4% shares (2026Q1 vs prior)
2 institutional holders · 5.9K shares
#1 Wealthspire Advisors, LLC 4.8K shares
#2 UBS Group AG 1.1K shares

📉 Short Interest

Short Interest71.1K
Days to Cover2.7
% of Float1.8%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Sep 30, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track GDTC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GDTC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for GDTC
📊 GDTC FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GDTC Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.